C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy

References

• Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014; 10:661-70; PMID:25311585; https://doi.org/10.1038/nrneurol.2014.184
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. Neuron 2011; 72:245-56; PMID:21944778; https://doi.org/10.1016/j.neuron.2011.09.011
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72:257-68; PMID:21944779; https://doi.org/10.1016/j.neuron.2011.09.010
   PubMed Web of Science ®Google Scholar
• Donnelly CJ, Zhang PW, Pham JT, Heusler AR, Mistry Na, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 2013; 80:415-28; PMID:24139042; https://doi.org/10.1016/j.neuron.2013.10.015
   PubMed Web of Science ®Google Scholar
• Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A 2013; 110:E4530-9; PMID:24170860; https://doi.org/10.1073/pnas.1318835110
   PubMed Web of Science ®Google Scholar
• Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Fratta P, Isaacs AM. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol 2013; 126:845-57; PMID:24170096; https://doi.org/10.1007/s00401-013-1200-z
   PubMed Web of Science ®Google Scholar
• Mori K, Lammich S, Mackenzie IRA, Forné I, Zilow S, Kretzschmar H, Edbauer D, Janssens J, Kleinberger G, Cruts M, et al. HnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol 2013; 125:413-23; PMID:23381195; https://doi.org/10.1007/s00401-013-1088-7
   PubMed Web of Science ®Google Scholar
• Sareen D, O'Rourke JG, Meera P, Muhammad AKMG, Grant S, Simpkinson M, Bell S, Carmona S, Ornelas L, Sahabian A, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Translational Med 2013; 5:208ra149; PMID:24154603; https://doi.org/10.1126/scitranslmed.3007529
   PubMed Web of Science ®Google Scholar
• Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW, 3rd, Rademakers R, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 2013; 77:639-46; PMID:23415312; https://doi.org/10.1016/j.neuron.2013.02.004
   PubMed Web of Science ®Google Scholar
• Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PEa, Caulfield T, Daughrity L, Dunmore JH, Castanedes-Casey M, Chew J, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol 2013; 126:829-44; PMID:24129584; https://doi.org/10.1007/s00401-013-1192-8
   PubMed Web of Science ®Google Scholar
• Mizielinska S, Grönke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, Moens T, Norona FE, Woollacott IO, Pietrzyk J, et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science (New York, NY) 2014; 16:1131-5
   Google Scholar
• Mori K, Arzberger T, Grässer FA, Gijselinck I, May S, Rentzsch K, Weng SM, Schludi MH, van der Zee J, Cruts M, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 2013; 126:881-93; PMID:24132570; https://doi.org/10.1007/s00401-013-1189-3
   PubMed Web of Science ®Google Scholar
• Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science (New York, NY) 2013; 339:1335-8; https://doi.org/10.1126/science.1232927
   Google Scholar
• Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, Pregent L, Daughrity L, Baker MC, Rademakers R, et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol 2013; 126:895-905; PMID:24166615; https://doi.org/10.1007/s00401-013-1199-1
   PubMed Web of Science ®Google Scholar
• Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, Kabashi E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Annals Neurol 2013; 74:180-7; PMID:23720273
   PubMed Web of Science ®Google Scholar
• Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 2012; 135:751-64; PMID:22366792; https://doi.org/10.1093/brain/awr365
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol 2012; 11:54-65; PMID:22154785; https://doi.org/10.1016/S1474-4422(11)70261-7
   PubMed Web of Science ®Google Scholar
• Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, Zheng Y, Ghani M, Dib S, Keith J, et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genetics 2013; 92:981-9; PMID:23731538; https://doi.org/10.1016/j.ajhg.2013.04.017
   PubMed Web of Science ®Google Scholar
• Waite AJ, Bäumer D, East S, Neal J, Morris HR, Ansorge O, Blake DJ. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging 2014; 35:1779.e5-1779.e13; PMID:24559645; https://doi.org/10.1016/j.neurobiolaging.2014.01.016
   PubMed Web of Science ®Google Scholar
• Xiao S, Macnair L, Mcgoldrick P, Mckeever PM, Robertson J. Isoform specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann Neurol 2015; 78(4):568-83; PMID:26174152
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, et al. Gain of toxicity from ALS/FTD-Linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron 2016; 90:535-50; PMID:27112497; https://doi.org/10.1016/j.neuron.2016.04.006
   PubMed Web of Science ®Google Scholar
• Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, Yachnis AT, Ranum LP. C9orf72 BAC mouse model with motor deficits and Neurodegenerative features of ALS/FTD. Neuron 2016; 90:521-34; PMID:27112499; https://doi.org/10.1016/j.neuron.2016.04.005
   PubMed Web of Science ®Google Scholar
• O'Rourke JG, Bogdanik L, Yáñez A, Lall D, Wolf AJ, Muhammad AKMG, Ho R, Carmona S, Vit JP, Zarrow J, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science 2016; 351:1324-9; PMID:Can't; https://doi.org/10.1126/science.aaf1064
   PubMed Web of Science ®Google Scholar
• Peters OM, Cabrera GT, Tran H, Gendron TF, McKeon JE, Metterville J, Weiss A, Wightman N, Salameh J, Kim J, et al. Human C9ORF72 Hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not Neurodegeneration in BAC transgenic mice. Neuron 2015; 88:902-9; PMID:26637797; https://doi.org/10.1016/j.neuron.2015.11.018
   PubMed Web of Science ®Google Scholar
• Atanasio A, Decman V, White D, Ramos M, Ikiz B, Lee HC, Siao CJ, Brydges S, LaRosa E, Bai Y, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Scientific Reports 2016; 6:23204; PMID:26979938; https://doi.org/10.1038/srep23204
   PubMed Web of Science ®Google Scholar
• Burberry A, Suzuki N, Wang JY, Moccia R, Mordes DA, Stewart MH, Suzuki-Uematsu S, Ghosh S, Singh A, Merkle FT, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Translational Med 2016; 8:347ra93-ra93; PMID:27412785; https://doi.org/10.1126/scitranslmed.aaf6038
   PubMed Web of Science ®Google Scholar
• Sudria-Lopez E, Koppers M, de Wit M, van der Meer C, Westeneng HJ, Zundel CAC, Youssef SA, Harkema L, de Bruin A, Veldink JH, et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol 2016; 132:145-7; PMID:27206760; https://doi.org/10.1007/s00401-016-1581-x
   PubMed Web of Science ®Google Scholar
• Sullivan PM, Zhou X, Robins AM, Paushter DH, Kim D, Smolka MB, Hu F. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathologica Commun 2016; 4:51; PMID:27193190; https://doi.org/10.1186/s40478-016-0324-5
   PubMed Web of Science ®Google Scholar
• Koppers M, Blokhuis AM, Westeneng HJ, Terpstra ML, Zundel CaC, Vieira de Sá R, Schellevis RD, Waite AJ, Blake DJ, Veldink JH, et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Annals Neurol 2015; 78(3):426-38: n/a-n/a; PMID:26044557
   PubMed Web of Science ®Google Scholar
• Levine TP, Daniels RD, Gatta AT, Wong LH, Hayes MJ. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics 2013; 29:499-503; PMID:23329412; https://doi.org/10.1093/bioinformatics/bts725
   PubMed Web of Science ®Google Scholar
• Zhang D, Iyer LM, He F, Aravind L. Discovery of novel DENN proteins: Implications for the evolution of eukaryotic intracellular membrane structures and human disease. Frontiers Genetics 2012; 3:283
   PubMedGoogle Scholar
• Ao X, Zou L, Wu Y. Regulation of autophagy by the Rab GTPase network. Cell Death Differentiation 2014; 21:348-58; PMID:24440914; https://doi.org/10.1038/cdd.2013.187
   PubMed Web of Science ®Google Scholar
• Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009; 10:513-25; PMID:19603039; https://doi.org/10.1038/nrm2728
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Bento CF, Deretic V. Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. J Exp Med 2015; 212:979-90; PMID:26101267; https://doi.org/10.1084/jem.20150956
   PubMed Web of Science ®Google Scholar
• Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, Rogelj B, Al-Chalabi A, Hortobágyi T, Shaw CE. P62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 2011; 122:691-702; PMID:22101323; https://doi.org/10.1007/s00401-011-0911-2
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Frick P, Neumann M. The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 2014; 127:347-57; PMID:24356984; https://doi.org/10.1007/s00401-013-1232-4
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G, Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy*[S]. J Biol Chem 2007; 282:24131-45
   PubMed Web of Science ®Google Scholar
• Kabeya Y. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19(21):5720-8; PMID:11060023; https://doi.org/10.1093/emboj/19.21.5720
   PubMed Web of Science ®Google Scholar
• Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, Myszczynska MA, Higginbottom A, Walsh MJ, Whitworth AJ, et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J 2016; 35(15):1656-76; PMID:27334615
   PubMed Web of Science ®Google Scholar
• Sellier C, Campanari ML, Julie Corbier C, Gaucherot A, Kolb‐Cheynel I, Oulad‐Abdelghani M, Ruffenach F, Page A, Ciura S, Kabashi E, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin‐2 to induce motor neuron dysfunction and cell death. EMBO J 2016; 35:1276-97; PMID:27103069; https://doi.org/10.15252/embj.201593350
   PubMed Web of Science ®Google Scholar
• Ganley IG, Lam DH, Wang J, Ding X, Chen S, Jiang X. ULK1·ATG13·FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009; 284:12297-305; PMID:19258318; https://doi.org/10.1074/jbc.M900573200
   PubMed Web of Science ®Google Scholar
• Hara T, Takamura A, Kishi C, Iemura SI, Natsume T, Guan JL, Mizushima N. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol 2008; 181:497-510; PMID:18443221; https://doi.org/10.1083/jcb.200712064
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Sasaki T, Iemura SI, Natsume T, Hara T, Mizushima N. Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy 2009; 5:973-9; PMID:19597335; https://doi.org/10.4161/auto.5.7.9296
   PubMed Web of Science ®Google Scholar
• Mercer CA, Kaliappan A, Dennis PB. A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy. Autophagy 2009; 5:649-62; PMID:19287211; https://doi.org/10.4161/auto.5.5.8249
   PubMed Web of Science ®Google Scholar
• Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010; 466:68-76; PMID:20562859; https://doi.org/10.1038/nature09204
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; https://doi.org/10.1038/ncb2152
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20:1992-2003; PMID:19225151; https://doi.org/10.1091/mbc.E08-12-1249
   PubMed Web of Science ®Google Scholar
• Karanasios E, Stapleton E, Manifava M, Kaizuka T, Mizushima N, Walker SA, Ktistakis NT. Dynamic association of the ULK1 complex with omegasomes during autophagy induction. J Cell Sci 2013; 126:5224-38; PMID:24013547; https://doi.org/10.1242/jcs.132415
   PubMed Web of Science ®Google Scholar
• Wang J, Menon S, Yamasaki A, Chou HT, Walz T, Jiang Y, Ferro-Novick S. Ypt1 recruits the Atg1 kinase to the preautophagosomal structure. Proc Natl Acad Sci U S A 2013; 110:9800-5; PMID:23716696; https://doi.org/10.1073/pnas.1302337110
   PubMed Web of Science ®Google Scholar
• Zoppino FCM, Militello RD, Slavin I, Álvarez C, Colombo MI. Autophagosome formation depends on the small GTPase rab1 and functional ER exit sites. Traffic 2010; 11:1246-61; PMID:20545908; https://doi.org/10.1111/j.1600-0854.2010.01086.x
   PubMed Web of Science ®Google Scholar
• Meiling-Wesse K, Epple UD, Krick R, Barth H, Appelles A, Voss C, Eskelinen EL, Thumm M. Trs85 (Gsg1), a component of the TRAPP complexes, is required for the organization of the Preautophagosomal structure during selective autophagy via the Cvt pathway. J Biol Chem 2005; 280:33669-78; PMID:16079147; https://doi.org/10.1074/jbc.M501701200
   PubMed Web of Science ®Google Scholar
• Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, et al. α-Synuclein impairs macroautophagy: implications for Parkinson disease. J Cell Biol 2010; 190:1023-37; PMID:20855506; https://doi.org/10.1083/jcb.201003122
   PubMed Web of Science ®Google Scholar
• Amick J, Roczniak-Ferguson A, Ferguson SM. C9orf72 binds SMCR8, localizes to lysosomes and regulates mTORC1 signaling. Mol Biol Cell 2016; PMID:27559131; https://doi.org/10.1091/mbc.E16-01-0003
   Google Scholar
• Yang M, Liang C, Swaminathan K, Herrlinger S, Lai F, Shiekhattar R, Chen JF. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv 2016; 2:e1601167
   PubMed Web of Science ®Google Scholar
• Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 2011; 91:119-49; PMID:21248164; https://doi.org/10.1152/physrev.00059.2009
   PubMed Web of Science ®Google Scholar
• Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, Dupont N, Ornatowski W, Jiang S, Bradfute SB, et al. TBK-1 Promotes Autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 2012; 37:223-34; PMID:22921120; https://doi.org/10.1016/j.immuni.2012.04.015
   PubMed Web of Science ®Google Scholar
• Seto S, Sugaya K, Tsujimura K, Nagata T, Horii T, Koide Y. Rab39a interacts with Phosphatidylinositol 3-Kinase and negatively regulates autophagy induced by lipopolysaccharide stimulation in macrophages. PLoS One 2013; 8:e83324; PMID:24349490; https://doi.org/10.1371/journal.pone.0083324
   PubMed Web of Science ®Google Scholar
• Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013; 13:722-37; PMID:24064518; https://doi.org/10.1038/nri3532
   PubMed Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469:323-35; PMID:21248839; https://doi.org/10.1038/nature09782
   PubMed Web of Science ®Google Scholar
• Kuballa P, Nolte WM, Castoreno AB, Xavier RJ. Autophagy and the immune system. Annu Rev Immunol 2012; 30:611-46; PMID:22449030; https://doi.org/10.1146/annurev-immunol-020711-074948
   PubMed Web of Science ®Google Scholar
• Honda S, Arakawa S, Nishida Y, Yamaguchi H, Ishii E, Shimizu S. Ulk1-mediated Atg5-independent macroautophagy mediates elimination of mitochondria from embryonic reticulocytes. Nat Commun 2014; 5:4004; https://doi.org/10.1038/ncomms5004
   PubMed Web of Science ®Google Scholar
• Zhu H, Foretz M, Xie Z, Zhang M, Zhu Z, Xing J, Leclerc J, Gaudry M, Viollet B, Zou MH. PRKAA1/AMPKα1 is required for autophagy-dependent mitochondrial clearance during erythrocyte maturation. Autophagy 2014; 10:1522-34; PMID:24988326; https://doi.org/10.4161/auto.29197
   PubMed Web of Science ®Google Scholar
• Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456:264-8; PMID:18849965; https://doi.org/10.1038/nature07383
   PubMed Web of Science ®Google Scholar
• Nedjic J, Aichinger M, Emmerich J, Mizushima N, Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008; 455:396-400; PMID:18701890; https://doi.org/10.1038/nature07208
   PubMed Web of Science ®Google Scholar
• Ahmad L, Zhang SY, Casanova JL, Sancho-Shimizu V. Human TBK1: A gatekeeper of Neuroinflammation. Trends Mol Med 2016; 22:511-27; PMID:27211305; https://doi.org/10.1016/j.molmed.2016.04.006
   PubMed Web of Science ®Google Scholar
• Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science (New York, NY) 2011; 333:228-33; https://doi.org/10.1126/science.1205405
   Google Scholar
• Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Müller K, Marroquin N, Nordin F, Hübers A, Weydt P, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 2015; 18:631-6; PMID:25803835; https://doi.org/10.1038/nn.4000
   PubMed Web of Science ®Google Scholar
• Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465:223-6; PMID:20428114; https://doi.org/10.1038/nature08971
   PubMed Web of Science ®Google Scholar
• O'Rourke JG, Bogdanik L, Muhammad AK, Gendron TF, Kim KJ, Austin A, Cady J, Liu EY, Zarrow J, Grant S, et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron 2015; 88:892-901; PMID:26637796; https://doi.org/10.1016/j.neuron.2015.10.027
   PubMed Web of Science ®Google Scholar
• Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302:113-7; PMID:14526083; https://doi.org/10.1126/science.1086071
   PubMed Web of Science ®Google Scholar
• Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, Ladner KJ, Bevan AK, Foust KD, Godbout JP, et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron 2014; 81:1009-23; PMID:24607225; https://doi.org/10.1016/j.neuron.2014.01.013
   PubMed Web of Science ®Google Scholar